dc.contributor.author |
Arhip, Cătălina
|
|
dc.date.accessioned |
2024-09-13T09:32:26Z |
|
dc.date.available |
2024-09-13T09:32:26Z |
|
dc.date.issued |
2024-03 |
|
dc.identifier.isbn |
978-9975-167-63-5 (PDF). |
|
dc.identifier.uri |
https://irek.ase.md:443/xmlui/handle/123456789/3574 |
|
dc.description |
ARHIP, Cătălina. Impactul crizei globale asupra cheltuielilor cu cercetarea, dezvoltarea și inovarea în industria farmaceutică = Impact of the Global Crisis on R&D and Innovation Spending in the Pharmaceutical Industry. In: Challenges of accounting for young researchers [online]: international student scientific conference, ISSC 2024, 8th Edition, March 15-16, 2024: Collection of scientific articles. Chişinău: SEP ASEM, 2024, pp. 248-250. ISBN 978-9975-167-63-5 (PDF). |
en_US |
dc.description.abstract |
In this research I set out to analyse the impact of the global crisis on R&D and innovation expenditure in the pharmaceutical industry. The global crisis that started during the pandemic period has caused significant changes in the world's industries. In order to answer the research question, I analysed the pharmaceutical industry in Europe through the lens of published statistical data. The period analysed was 2020-2022. The findings highlight the impact of the global crisis on R&D and innovation spending in the pharmaceutical industry. CZU: 657.471:[661.12:001.891](100); JEL: M40; DOI: https://doi.org/10.53486/issc2024.59 |
en_US |
dc.language.iso |
other |
en_US |
dc.publisher |
ASEM |
en_US |
dc.subject |
pharmaceutical industry |
en_US |
dc.subject |
global crisis |
en_US |
dc.subject |
R&D |
en_US |
dc.subject |
innovation |
en_US |
dc.subject |
energy crisis |
en_US |
dc.subject |
artificial intelligence |
en_US |
dc.title |
Impactul crizei globale asupra cheltuielilor cu cercetarea, dezvoltarea și inovarea în industria farmaceutică |
en_US |
dc.title.alternative |
Impact of the Global Crisis on R&D and Innovation Spending in the Pharmaceutical Industry |
en_US |
dc.type |
Article |
en_US |